Raphael Pharmaceutical (RAPH) Operating Expenses (2020 - 2026)

Raphael Pharmaceutical has disclosed Operating Expenses across 7 years of filings, most recently posting $199000.0 for Q2 2026.

• In Q2 2026, Operating Expenses fell 36.83% year-over-year to $199000.0; the TTM figure through Jun 2026 stood at $1.2 million (down 3.92% YoY), while the FY2025 annual figure was $648000.0, down 12.79% from the prior year.
• Operating Expenses came in at $199000.0 for Q2 2026 at Raphael Pharmaceutical, down from $315000.0 in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $1.4 million in Q3 2022 to a low of -$74000.0 in Q4 2023.
• Average Operating Expenses over 5 years is $476571.4, with a median of $356500.0 recorded in 2024.
• Year-over-year, Operating Expenses tumbled 106.7% in 2023 and jumped 632.43% in 2024.
• Over 5 years, Operating Expenses stood at $1.1 million in 2022, then sank by 106.7% to -$74000.0 in 2023, then jumped by 632.43% to $394000.0 in 2024, then dropped by 20.05% to $315000.0 in 2025, then sank by 36.83% to $199000.0 in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $199000.0 in Q2 2026, $315000.0 in Q2 2025, and $394000.0 in Q4 2024.